Printer Friendly

Researchers aim to facilitate evidence-based decisions.

WASHINGTON -- A new framework developed by researchers at the National Pharmaceutical Council (NPC) and AcademyHealth is being touted as a way to bridge the gap between the "supply" of evidence developed by researchers and the "demand" for evidence by payers.

The gap stems from payers typically favoring evidence from randomized controlled trials over other study designs, including real-world or observational studies that are based upon electronic health records, patient registries or administrative claims, NPC remarked.

"This gap between supply and demand is complicated by the tendency of decision makers to assess evidence based on study design rather than whether the evidence credibly answers the question that's being asked," commented Jennifer Graff, vice president for comparative effectiveness research at NPC.

An article introducing the framework appears in the September issue of The American Journal of Managed Care.

COPYRIGHT 2015 Racher Press, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2015 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:RX/News
Publication:Chain Drug Review
Article Type:Brief article
Geographic Code:1USA
Date:Oct 26, 2015
Previous Article:Gaps in measurement hamper bid to improve quality.
Next Article:When it comes to Rx, convenience a big factor.

Terms of use | Privacy policy | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters